Value of CA 15-3 determination in the initial management of breast cancer patients.
Chourin
S
S
Georgescu
D
D
Gray
C
C
Guillemet
C
C
Loeb
A
A
Veyret
C
C
Basuyau
J-P
JP
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D018396:Mucin-1 / Q000032:analysis*; D009367:Neoplasm Staging; D018579:Patient Selection; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; C060192:MUC1 protein, human; D018396:Mucin-1